Over 15 million people in the United States suffer from macular degeneration, and almost 2 million of these patients have the advanced form of the disease. This course will highlight the risk factors that drive this disease, imaging modalities that are best suited for geographic atrophy evaluation, the type of lesion patterns that place patients at high risk for progression, and potential treatments. We will also focus on current research of emerging therapies.
Speaker: Joseph Pizzimenti, OD
